There’s a particular feeling I get reading medical news now, and it took me a while to name it. It’s the feeling of standing in a museum gift shop. Everything bright and reassuring, everything in your size, everything carefully not the actual thing.
I kept running into that feeling this week. A fentanyl vaccine made it to mice, and the headlines made it sound like the overdose crisis had found its answer. The mice are fine. Humans are years away. Meanwhile overdose deaths are already coming down for reasons we ought to be talking about more than a press release from a startup angling for Phase 1 in the Netherlands. And then a Cambridge cancer vaccine that “passed” its first trial. The trial finished in 2023. The press tour arrived this spring. The paper, when you sit with it, says the immune response was modest.
I am not against good news. I want the good news. But I keep noticing how often the announcement is louder than the finding, and how often the finding turns out to be a mouse, or a press release, or a patent application. The actual thing is what I owe you. It is quieter than the gift shop, and it is what we are here for.
Autoimmune & Inflammation
Your Thymus Quietly Stages a Lung. Researchers Just Named the Cell Playing the Part.
A new Nature Immunology study identifies an alveolar lung-like cell hiding inside the thymus, where it appears to teach the immune system not to attack your real lungs.
A near-starvation diet shifted inflammation in gum-disease patients. The trial was tiny, and the diet came in a box.
A 28-patient feasibility trial put severe gum-disease patients on three cycles of a 750-calorie ProLon diet. Inflammation markers trended lower; clinical gum measures weren’t reported. The biology question is real; the data is thin.
Drugs & FDA
A DoD-Funded Fentanyl Vaccine Is Headed to Phase 1. Antibodies Don’t Stop a Supply Chain.
A Pentagon-funded fentanyl vaccine licensed to startup ARMR Sciences will begin Phase 1 in the Netherlands in early 2026. Three decades of failed addiction vaccines, and a supply chain that runs through Chinese precursor labs, are the context the press release leaves out.
A Fentanyl Vaccine for Mice. An Overdose Decline for Humans.
Scripps Research published a clever chemistry redesign that let mice’s immune systems recognize an entire class of fentanyl analogues. The headlines called it an overdose blocker. The mice are doing fine. Humans are years away, and the overdose decline is already happening without it.
Cancer
A Korean lab found cancer’s DNA-repair off-switch. In a mouse.
A Korean state lab reports that a tool compound called UNI418 strips out the DNA-repair proteins cancer cells use to escape PARP inhibitors. The data are preclinical: cell lines and mouse xenografts. UNI418 is not yet a drug.
ALTAIR Missed Its Primary Endpoint. The Press Tour Found Something Else.
A phase 3 trial testing chemotherapy in ctDNA-positive colorectal cancer patients missed its primary endpoint at p=0.107, and a post-hoc reanalysis is doing the public-facing work.
Infectious Disease
The Battlefield Medicine Revolution Was Built on Fake Wounds
A British prosthetics graduate is heading to NHS ambulance crews and the British military to build realistic trauma wounds, the artisan end of the twenty-year battlefield-medicine revolution that turned hemorrhage into a survivable injury.
The AI Vaccine That ‘Passed’ Its First Trial Three Years Ago
Cambridge finished the Phase 1 trial in 2023. The press tour arrived in 2026. The paper, when you read it, said the immunogenicity was modest.
Brain & Aging
Brain Gains Into Your 90s Are Probably Real. The Index Measuring Them Has a Patent Pending.
A three-year UT Dallas study tracking nearly 4,000 adults to age 94 says brain function can climb at any age. The biology is plausible. The catch is that the people measuring the gain are the same people patenting the yardstick.
The Same Mutations That Drive Blood Cancer Keep Turning Up in Alzheimer’s Brains
A new Cell paper finds Alzheimer’s brains are riddled with the same mutations that drive blood cancers, in the immune cells that are supposed to be protecting neurons.
Nutrition & Food
8,300 Brazilian elders, one saltshaker, and the 80 percent of sodium nobody mentions
A Frontiers in Public Health survey of 8,336 Brazilians over 60 found older men reach for the saltshaker most. Buried in the same paper: the shaker only accounts for 6 to 20 percent of total sodium. The other 70-plus percent already arrived from the factory.
American Doctors Get About 1.2 Hours of Nutrition Training a Year. RFK Jr. Just Found the Lever.
Kennedy got eight organizations across U.S. medical training and 73 medical schools to commit to nutrition in licensing, accreditation, and a 40-hour pledge. The board exam matters; the rest is partly hedging.